WO2010048064A3 - Drug delivery system and its use in the treatment of postherpetic neuralgia - Google Patents

Drug delivery system and its use in the treatment of postherpetic neuralgia Download PDF

Info

Publication number
WO2010048064A3
WO2010048064A3 PCT/US2009/061114 US2009061114W WO2010048064A3 WO 2010048064 A3 WO2010048064 A3 WO 2010048064A3 US 2009061114 W US2009061114 W US 2009061114W WO 2010048064 A3 WO2010048064 A3 WO 2010048064A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin
drug delivery
postherpetic neuralgia
patients
treatment
Prior art date
Application number
PCT/US2009/061114
Other languages
French (fr)
Other versions
WO2010048064A2 (en
Inventor
Igor Kissin
Original Assignee
The Brigham And Women's Hospital, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Brigham And Women's Hospital, Inc. filed Critical The Brigham And Women's Hospital, Inc.
Publication of WO2010048064A2 publication Critical patent/WO2010048064A2/en
Publication of WO2010048064A3 publication Critical patent/WO2010048064A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics

Abstract

The present invention is directed to a drug delivery composition that can be used to topically apply drugs to the skin of patients. It is also directed to a method of treating patients for shingles or postherpetic neuralgia by using the device to occlusively apply topical anesthetic to skin areas without the need for adhesives that attach occlusive dressing to the patient skin. In addition, the invention includes a method for determining the dosing interval for administering topical anesthetic to patients with PHN in procedures involving the complete numbing of skin.
PCT/US2009/061114 2008-10-20 2009-10-18 Drug delivery system and its use in the treatment of postherpetic neuralgia WO2010048064A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13698408P 2008-10-20 2008-10-20
US61/136,984 2008-10-20

Publications (2)

Publication Number Publication Date
WO2010048064A2 WO2010048064A2 (en) 2010-04-29
WO2010048064A3 true WO2010048064A3 (en) 2010-07-08

Family

ID=42119913

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/061114 WO2010048064A2 (en) 2008-10-20 2009-10-18 Drug delivery system and its use in the treatment of postherpetic neuralgia

Country Status (1)

Country Link
WO (1) WO2010048064A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018225075A1 (en) * 2017-06-08 2018-12-13 Sol-Del Medical Ltd Devices for delivery of active agents to a target site
CN107714293A (en) * 2017-10-11 2018-02-23 赵坚 A kind of drug paste of cure scapulohumeral periarthritis
EP3886779A4 (en) * 2018-11-29 2022-06-22 Cannabidose Medical Ltd. Devices for topical delivery of active agents to a target site

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784857A (en) * 1986-06-03 1988-11-15 Smith And Nephew Associated Companies Plc Drug delivery device, its preparation and use
JPH07250864A (en) * 1994-03-11 1995-10-03 Tac Medical Kk Percutaneous absorption type preparation
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
US5629014A (en) * 1993-05-18 1997-05-13 Bertek, Inc. Foam laminate transdermal patch
US5891077A (en) * 1997-03-14 1999-04-06 Hollister Incorporated Thin film wound dressing with removable foraminous backing layer
JP2001057991A (en) * 1999-06-16 2001-03-06 Yuutoku Yakuhin Kogyo Kk Air permeable pasting agent and its production
US6756052B1 (en) * 1999-05-21 2004-06-29 Lts Lohmann Therapie-Systeme Ag Device and method for increasing the transdermal permeation of medicaments
WO2007065427A1 (en) * 2005-12-08 2007-06-14 Fertin Pharma Transdermal tobacco alkaloid patch

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784857A (en) * 1986-06-03 1988-11-15 Smith And Nephew Associated Companies Plc Drug delivery device, its preparation and use
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
US5629014A (en) * 1993-05-18 1997-05-13 Bertek, Inc. Foam laminate transdermal patch
JPH07250864A (en) * 1994-03-11 1995-10-03 Tac Medical Kk Percutaneous absorption type preparation
US5891077A (en) * 1997-03-14 1999-04-06 Hollister Incorporated Thin film wound dressing with removable foraminous backing layer
US6756052B1 (en) * 1999-05-21 2004-06-29 Lts Lohmann Therapie-Systeme Ag Device and method for increasing the transdermal permeation of medicaments
JP2001057991A (en) * 1999-06-16 2001-03-06 Yuutoku Yakuhin Kogyo Kk Air permeable pasting agent and its production
WO2007065427A1 (en) * 2005-12-08 2007-06-14 Fertin Pharma Transdermal tobacco alkaloid patch

Also Published As

Publication number Publication date
WO2010048064A2 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
MX2009005341A (en) Transdermal therapeutic system for administering the active substance buprenorphine.
MX2021004546A (en) Implantable drug delivery compositions and methods of use thereof.
IN2014DN09817A (en)
EP3501546A3 (en) Cysteine drug conjugates and use of same
MX2012014521A (en) Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation.
WO2015054619A8 (en) Use of a pcsk9 inhibitor to treat hyperlipidemia
WO2015066647A3 (en) Ionic liquids for transdermal drug delivery
WO2009134967A3 (en) Use of nucleic acids with reduced pressure therapy for treating wounds
MX2015007714A (en) Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective.
WO2013061083A3 (en) Therapeutic agents and uses thereof
WO2010091376A3 (en) Devices and methods for perfusion therapy
MX347195B (en) Transdermal drug delivery system and method of using the same.
AU2013299841A8 (en) Pharmaceutical combinations comprising a B-Raf inhibitor, an EGFR inhibitor and optionally a PI3K-alpha inhibitor
WO2014036556A3 (en) Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine
MX365688B (en) Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin.
ATE539747T1 (en) METHOD AND MEDICATION FOR ADMINISTRATION OF IBUPROFEN
NZ630040A (en) Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
EP2407147A3 (en) Composition with bio-rigenerative, restorative and eutrophying activity
MX2013012206A (en) Method of producing substances with supersaturated gas, transdermal delivery thereof, and uses thereof.
WO2010048064A3 (en) Drug delivery system and its use in the treatment of postherpetic neuralgia
WO2008063563A3 (en) Methods of treating keratin hyperproliferation disorders using mtor inhibitors
MX2010006724A (en) Therapeutic regimens for the treatment of immunoinflammatory disorders.
MX2013012204A (en) Method of producing substances with supersaturated gas,transdermal delivery device thereof, and uses thereof.
MX2013012205A (en) Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof.
WO2013010137A3 (en) A composition, device and method for delayed and sustained release of brain energy molecules

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09822489

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09822489

Country of ref document: EP

Kind code of ref document: A2